Philadelphia-based Stem cell startup secures US$250 million funding
By Rajaneesh K. Gopinath, Ph.D. Three years since launching BlueRock Therapeutics with a $225 million series A funding, Bayer and Versant Ventures are once again firmly investing in stem cell …
Read More